Oncotelic Provides Ye 2021 Financial Results Compared To Ye 2020, Product Developmet Initiatives And Corporate Update
AGOURA HILLS, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Firm”) (OTCQB:OTLC) at the ...
